Holland & Knight advised Savara on the offering. Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $100 million...
You must be a Standard 1 Year member to access this content.
Holland & Knight advised Advanced MedAesthetic Partners on the deal. Advanced MedAesthetic Partners (AMP) announced its new alliance with Blush Med Spa, a medical aesthetics practice...
You must be a Standard 1 Year member to access this content.
Holland & Knight advised Lincoln Road Global Management, LLC on the deal. Lincoln Road Global Management, LLC announced its acquisition of Zodega, a provider of full-service...
You must be a Standard 1 Year member to access this content.
Holland & Knight advised Advanced MedAesthetic Partners on the deal. Advanced MedAesthetic Partners announced its strategic investment in Destination Aesthetics. The deal was announced on March 17,...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...
You must be a Standard 1 Year member to access this content.
Weil, Gotshal & Manges represented Sanofi in the transaction. Sanofi, a global biopharmaceutical company focused on human health, executed its $1.9 billion acquisition of Kadmon Holdings, Inc.,...
You must be a Standard 1 Year member to access this content.
Hogan Lovells and Kramer Levin advised VICI Properties, Inc. on the deal. Sullivan & Cromwell represented the Lenders. Baker Botts represented MGM Growth Properties. Weil, Gotshal...
You must be a Standard 1 Year member to access this content.
